Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 3528

1.

Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.

Tanaka F, Hashimoto W, Okamura H, Robbins PD, Lotze MT, Tahara H.

Cancer Res. 2000 Sep 1;60(17):4838-44.

2.

Dendritic cell-tumor coculturing vaccine can induce antitumor immunity through both NK and CTL interaction.

Kim KD, Choi SC, Kim A, Choe YK, Choe IS, Lim JS.

Int Immunopharmacol. 2001 Nov;1(12):2117-29.

PMID:
11710541
3.

Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells.

Yu Y, Hagihara M, Ando K, Gansuvd B, Matsuzawa H, Tsuchiya T, Ueda Y, Inoue H, Hotta T, Kato S.

J Immunol. 2001 Feb 1;166(3):1590-600.

4.

Administration of interleukin-12 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines in mouse hepatocellular carcinoma.

Tatsumi T, Takehara T, Kanto T, Miyagi T, Kuzushita N, Sugimoto Y, Jinushi M, Kasahara A, Sasaki Y, Hori M, Hayashi N.

Cancer Res. 2001 Oct 15;61(20):7563-7.

5.

Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18.

Lauwerys BR, Garot N, Renauld JC, Houssiau FA.

J Immunol. 2000 Aug 15;165(4):1847-53.

6.
7.

Apoptotic pancreatic tumor cells are superior to cell lysates in promoting cross-priming of cytotoxic T cells and activate NK and gammadelta T cells.

Schnurr M, Scholz C, Rothenfusser S, Galambos P, Dauer M, Röbe J, Endres S, Eigler A.

Cancer Res. 2002 Apr 15;62(8):2347-52.

8.

Synergistic interleukin-18 and low-dose interleukin-2 promote regression of established murine neuroblastoma in vivo.

Redlinger RE Jr, Mailliard RB, Lotze MT, Barksdale EM Jr.

J Pediatr Surg. 2003 Mar;38(3):301-7; discussion 301-7.

PMID:
12632339
11.

In vivo antitumor activity of NKT cells activated by the combination of IL-12 and IL-18.

Baxevanis CN, Gritzapis AD, Papamichail M.

J Immunol. 2003 Sep 15;171(6):2953-9.

12.
14.

APC stimulated by CpG oligodeoxynucleotide enhance activation of MHC class I-restricted T cells.

Warren TL, Bhatia SK, Acosta AM, Dahle CE, Ratliff TL, Krieg AM, Weiner GJ.

J Immunol. 2000 Dec 1;165(11):6244-51.

15.

Murine dendritic cells pulsed with an anti-idiotype antibody induce antigen-specific protective antitumor immunity.

Saha A, Chatterjee SK, Foon KA, Primus FJ, Bhattacharya-Chatterjee M.

Cancer Res. 2003 Jun 1;63(11):2844-54.

17.

DC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL induction.

Adam C, King S, Allgeier T, Braumüller H, Lüking C, Mysliwietz J, Kriegeskorte A, Busch DH, Röcken M, Mocikat R.

Blood. 2005 Jul 1;106(1):338-44. Epub 2005 Mar 15.

18.

Interleukin-12 activates NK cells for IFN-gamma-dependent and NKT cells for IFN-gamma-independent antimetastatic activity.

Hafner M, Falk W, Echtenacher B, Männel DN.

Eur Cytokine Netw. 1999 Dec;10(4):541-8.

PMID:
10586121
19.

Critical role of MHC class I-related chain A and B expression on IFN-alpha-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection.

Jinushi M, Takehara T, Kanto T, Tatsumi T, Groh V, Spies T, Miyagi T, Suzuki T, Sasaki Y, Hayashi N.

J Immunol. 2003 Feb 1;170(3):1249-56.

Items per page

Supplemental Content

Write to the Help Desk